These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 8850326

  • 1. Concanamycin B, a vacuolar H(+)-ATPase specific inhibitor suppresses bone resorption in vitro.
    Woo JT, Ohba Y, Tagami K, Sumitani K, Yamaguchi K, Tsuji T.
    Biol Pharm Bull; 1996 Feb; 19(2):297-9. PubMed ID: 8850326
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of bone resorption in vitro by antisense RNA and DNA molecules targeted against carbonic anhydrase II or two subunits of vacuolar H(+)-ATPase.
    Laitala T, Väänänen HK.
    J Clin Invest; 1994 Jun; 93(6):2311-8. PubMed ID: 8200964
    [Abstract] [Full Text] [Related]

  • 3. Expression of vacuolar H(+)-ATPase in osteoclasts and its role in resorption.
    Sasaki T, Hong MH, Udagawa N, Moriyama Y.
    Cell Tissue Res; 1994 Nov; 278(2):265-71. PubMed ID: 8001083
    [Abstract] [Full Text] [Related]

  • 4. Inhibitory mechanisms of H(+)-ATPase inhibitor bafilomycin A1 and carbonic anhydrase II inhibitor acetazolamide on experimental bone resorption.
    Ohba Y, Ohba T, Sumitani K, Tagami-Kondoh K, Hiura K, Miki Y, Kakegawa H, Takano-Yamamoto T, Katunuma N.
    FEBS Lett; 1996 Jun 03; 387(2-3):175-8. PubMed ID: 8674544
    [Abstract] [Full Text] [Related]

  • 5. A pharmacological assessment of the mammalian osteoclast vacuolar H(+)-ATPase.
    Hall TJ, Schaueblin M.
    Bone Miner; 1994 Nov 03; 27(2):159-66. PubMed ID: 7711523
    [Abstract] [Full Text] [Related]

  • 6. Inhibitors of vacuolar-type H(+)-ATPase suppresses proliferation of cultured cells.
    Manabe T, Yoshimori T, Henomatsu N, Tashiro Y.
    J Cell Physiol; 1993 Dec 03; 157(3):445-52. PubMed ID: 8253855
    [Abstract] [Full Text] [Related]

  • 7. Omeprazole and bafilomycin, two proton pump inhibitors: differentiation of their effects on gastric, kidney and bone H(+)-translocating ATPases.
    Mattsson JP, Väänänen K, Wallmark B, Lorentzon P.
    Biochim Biophys Acta; 1991 Jun 18; 1065(2):261-8. PubMed ID: 1647821
    [Abstract] [Full Text] [Related]

  • 8. [3H]Bafilomycin as a probe for the transmembrane proton channel of the osteoclast vacuolar H(+)-ATPase.
    Mattsson JP, Keeling DJ.
    Biochim Biophys Acta; 1996 Apr 03; 1280(1):98-106. PubMed ID: 8634321
    [Abstract] [Full Text] [Related]

  • 9. Diphyllin, a novel and naturally potent V-ATPase inhibitor, abrogates acidification of the osteoclastic resorption lacunae and bone resorption.
    Sørensen MG, Henriksen K, Neutzsky-Wulff AV, Dziegiel MH, Karsdal MA.
    J Bone Miner Res; 2007 Oct 03; 22(10):1640-8. PubMed ID: 17576165
    [Abstract] [Full Text] [Related]

  • 10. Bovine parathyroid hormone enhances osteoclast bone resorption by modulating V-ATPase through PTH1R.
    Liu S, Zhu W, Li S, Ma J, Zhang H, Li Z, Zhang L, Zhang B, Li Z, Liang X, Shi W.
    Int J Mol Med; 2016 Feb 03; 37(2):284-92. PubMed ID: 26647715
    [Abstract] [Full Text] [Related]

  • 11. Specific inhibitors of vacuolar type H(+)-ATPases induce apoptotic cell death.
    Nishihara T, Akifusa S, Koseki T, Kato S, Muro M, Hanada N.
    Biochem Biophys Res Commun; 1995 Jul 06; 212(1):255-62. PubMed ID: 7612014
    [Abstract] [Full Text] [Related]

  • 12. Mutations of pma-1, the gene encoding the plasma membrane H+-ATPase of Neurospora crassa, suppress inhibition of growth by concanamycin A, a specific inhibitor of vacuolar ATPases.
    Bowman EJ, O'Neill FJ, Bowman BJ.
    J Biol Chem; 1997 Jun 06; 272(23):14776-86. PubMed ID: 9169444
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of osteoclast proton transport by bafilomycin A1 abolishes bone resorption.
    Sundquist K, Lakkakorpi P, Wallmark B, Väänänen K.
    Biochem Biophys Res Commun; 1990 Apr 16; 168(1):309-13. PubMed ID: 2139331
    [Abstract] [Full Text] [Related]

  • 14. A vacuolar ATPase inhibitor, FR167356, prevents bone resorption in ovariectomized rats with high potency and specificity: potential for clinical application.
    Niikura K, Takeshita N, Takano M.
    J Bone Miner Res; 2005 Sep 16; 20(9):1579-88. PubMed ID: 16059630
    [Abstract] [Full Text] [Related]

  • 15. Tissue-selective inhibition of vacuolar acid pumps.
    Keeling DJ, Herslöf M, Mattsson JP, Ryberg B.
    Acta Physiol Scand Suppl; 1998 Aug 16; 643():195-201. PubMed ID: 9789561
    [No Abstract] [Full Text] [Related]

  • 16. Destruxin B, a specific and readily reversible inhibitor of vacuolar-type H(+)-translocating ATPase.
    Muroi M, Shiragami N, Takatsuki A.
    Biochem Biophys Res Commun; 1994 Dec 15; 205(2):1358-65. PubMed ID: 7802670
    [Abstract] [Full Text] [Related]

  • 17. Specific inhibitors of vacuolar H(+)-ATPase trigger apoptotic cell death of osteoclasts.
    Okahashi N, Nakamura I, Jimi E, Koide M, Suda T, Nishihara T.
    J Bone Miner Res; 1997 Jul 15; 12(7):1116-23. PubMed ID: 9200012
    [Abstract] [Full Text] [Related]

  • 18. Prodigiosin 25-C and metacycloprodigiosin suppress the bone resorption by osteoclasts.
    Woo JT, Ohba Y, Tagami K, Sumitani K, Kataoka T, Nagai K.
    Biosci Biotechnol Biochem; 1997 Feb 15; 61(2):400-2. PubMed ID: 9058987
    [Abstract] [Full Text] [Related]

  • 19. Increase in Bcl-2 level promoted by CD40 ligation correlates with inhibition of B cell apoptosis induced by vacuolar type H(+)-ATPase inhibitor.
    Akifusa S, Ohguchi M, Koseki T, Nara K, Semba I, Yamato K, Okahashi N, Merino R, Núñez G, Hanada N, Takehara T, Nishihara T.
    Exp Cell Res; 1998 Jan 10; 238(1):82-9. PubMed ID: 9457059
    [Abstract] [Full Text] [Related]

  • 20. Acidification is essential for maintaining the structure and function of lytic granules of CTL. Effect of concanamycin A, an inhibitor of vacuolar type H(+)-ATPase, on CTL-mediated cytotoxicity.
    Kataoka T, Takaku K, Magae J, Shinohara N, Takayama H, Kondo S, Nagai K.
    J Immunol; 1994 Nov 01; 153(9):3938-47. PubMed ID: 7930604
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.